A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.

Kanankulam Velliangiri, Sivasankar; Ballal, Sanjana; Prasad Yadhav, Madhav; Tripathi, Madhavi; Satapathy, Swayamjeet; Bal, Chandrasekhar

Kanankulam Velliangiri, Sivasankar; Ballal, Sanjana; Prasad Yadhav, Madhav; Tripathi, Madhavi; Satapathy, Swayamjeet; Bal, Chandrasekhar.

Afiliação

Kanankulam Velliangiri S; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Ballal S; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Prasad Yadhav M; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Tripathi M; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Satapathy S; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Bal C; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.

PLoS One ; 18(11): e0294343, 2023.

Article em En | MEDLINE | ID: mdl-37963164

Assuntos

Adenocarcinoma Folicular; Neoplasias da Glândula Tireoide; Humanos; Feminino; Pessoa de Meia-Idade; Masculino; Estudos Retrospectivos; Radioisótopos do Iodo/uso terapêutico; Neoplasias da Glândula Tireoide/patologia; Adenocarcinoma Folicular/radioterapia; Tireoidectomia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Adenocarcinoma Folicular Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google